首页|期刊导航|临床与病理杂志|4例伴淋巴样间质胃癌的临床病理特征

4例伴淋巴样间质胃癌的临床病理特征OA

Clinicopathological features of 4 cases of gastric carcinoma with lymphoid stroma

中文摘要英文摘要

目的:伴淋巴样间质胃癌(gastric carcinoma with lymphoid stroma,GCLS)是一种罕见的胃癌亚型.该肿瘤主要与EB病毒(Epstein-Barr virus,EBV)感染或错配修复功能缺陷(deficient mismatch repair,dMMR)/微卫星高度不稳定(microsatellite instability-high,MSI-H)相关,具有独特的分子特征和免疫微环境.本研究旨在回顾性分析4例GCLS病例的临床病理及分子特征,探讨GCLS的诊断要点、分子分型特点及免疫治疗潜力,以期提高临床及病理医师对该肿瘤的认识,为其个体化治疗提供参考依据.方法:收集2021年10月至2022年5月中国人民解放军总医院第一医学中心病理科确诊的4例GCLS病例,回顾性分析其临床资料、病理形态学特征及免疫微环境特点.采用免疫组织化学(immunohistochemistry,IHC)检测错配修复(mismatch repair,MMR)蛋白[包括减数分裂后分离增强蛋白2(post-meiotic segregation increased 2,PMS2)、MutL 同源物 1(MutL homolog 1,MLH1)、MutS 同源物(MutS homolog,MSH)2、MSH6]、人表皮生长因子受体 2(human epidermal growth factor receptor 2,HER2)、分化抗原(cluster of differentiation,CD)4、CD8及程序性死亡受体配体1(programmed death‐ligand 1,PD‐L1)(SP263)的表达情况;采用EB病毒编码的小RNA(Epstein-Barr virus-encoded small RNA,EBER)原位杂交检测EBV的感染状态;采用二代测序(next-generation sequencing,NGS)技术检测40个肿瘤相关基因(包括EGFR、KRAS、PIK3CA、ERBB2等)的点突变、插入缺失、融合及拷贝数扩增情况,并评估微卫星不稳定性(microsatellite instability,MSI)状态.结果:4例GCLS患者中,男性3例,女性1例,确诊年龄为56~72岁.肿瘤位于胃体(2例)、胃底(1例)及胃底体交界(1例).组织学上所有病例均为低分化癌,肿瘤细胞呈卵圆形、多角形,呈巢团状、片状分布,间质淋巴细胞浸润显著(50%~80%),部分可见淋巴滤泡形成,伴脉管癌栓及神经侵犯.根据分子检测及IHC检测结果可将病例分为2种分子亚型:3例为EBER阳性/错配修复功能正常(proficient mismatch repair,pMMR)/微卫星稳定(microsatellite stable,MSS)型,均携带PIK3CA突变,分别合并MAP2K1、ERBB2+CTNNB1、PTEN突变,HER2多为阴性或低表达,PD-L1呈高表达;另1例为EBER阴性/dMMR/MSI-H型,伴KRAS p.G12D突变,MLH1、PMS2、MSH6蛋白表达均缺失.所有病例CD8/CD4比值均>1,肿瘤微环境富含T细胞.结论:GCLS是一种罕见的胃癌亚型,具有独特的病理形态和分子特征,可分为2种分子亚型:EBER阳性/pMMR/MSS型以PIK3CA突变为核心分子特征;EBV阴性/dMMR/MSI-H型可见KRAS突变与MMR蛋白缺失表达.2种亚型均存在PD-L1高表达及丰富的淋巴细胞浸润,提示该类患者具有免疫治疗的潜在获益可能.

Objective:Gastric carcinoma with lymphoid stroma(GCLS)is a rare subtype of gastric carcinoma.It is mainly associated with Epstein-Barr virus(EBV)infection or deficient mismatch repair(dMMR)/microsatellite instability-high(MSI-H)status and exhibits distinctive molecular characteristics and an immune microenvironment.This study aims to retrospectively analyze the clinicopathological and molecular features of 4 cases of GCLS,explore its key diagnostic features,molecular subtypes,and potential for immunotherapy,and thereby improve clinicians'and pathologists'understanding of this tumor and provide a reference for individualized treatment. Methods:Four cases of GCLS diagnosed in the Department of Pathology,The First Medical Center of Chinese PLA General Hospital,between October 2021 and May 2022 were collected.Their clinical data,histopathological features,and characteristics of the immune microenvironment were retrospectively analyzed.Immunohistochemistry(IHC)was performed to assess the expression of mismatch repair(MMR)proteins,including post-meiotic segregation increased 2(PMS2),MutL homolog 1(MLH1),MutS homolog 2(MSH2),and MSH6,as well as human epidermal growth factor receptor 2(HER2),cluster of differentiation 4(CD4),CD8,and programmed death-ligand 1(PD-L1,clone SP263).Epstein-Barr virus-encoded small RNA(EBER)in situ hybridization was used to determine EBV infection status.Next-generation sequencing(NGS)was performed to detect point mutations,insertions/deletions,gene fusions,and copy-number amplifications in 40 tumor-related genes,including EGFR,KRAS,PIK3CA,and ERBB2,and microsatellite instability(MSI)status was also assessed. Results:Among the 4 patients with GCLS,3 were men and 1 was a woman.The patients were 56−72 years old at diagnosis.Tumors were located in the gastric body in 2 cases,the gastric fundus in 1 case,and the fundus-body junction in 1 case.Histologically,all tumors were poorly differentiated carcinomas.The tumor cells were oval to polygonal and arranged in nests and sheets,with prominent stromal lymphocytic infiltration(50%−80%).Lymphoid follicle formation was observed in some cases,and occasional cases showed lymphovascular tumor emboli and perineural invasion.Based on the molecular and IHC findings,the 4 cases could be classified into 2 molecular subtypes.Three cases were EBER-positive/pMMR/MSS and all harbored PIK3CA mutations,accompanied respectively by MAP2K1,ERBB2 plus CTNNB1,and PTEN mutations.HER2 was predominantly negative or showed low expression,whereas PD-L1 expression was high.The remaining case was EBER-negative/dMMR/MSI-H,harbored a KRAS p.G12D mutation,and showed loss of MLH1,PMS2,and MSH6 expression.The CD8/CD4 ratio was>1 in all cases,indicating a T-lymphocyte-rich tumor microenvironment. Conclusion:GCLS is a rare subtype of gastric carcinoma with distinctive histopathological and molecular features.It can be broadly divided into 2 molecular subtypes:the EBER-positive/pMMR/MSS subtype,characterized predominantly by PIK3CA mutations,and the EBER-negative/dMMR/MSI-H subtype,which may harbor KRAS mutations and loss of MMR protein expression.Both subtypes show high PD-L1 expression and prominent lymphocytic infiltration,suggesting that patients with GCLS may potentially benefit from immunotherapy.

刘金楠;董周寰;朱凤伟;田侠;袁静

中国人民解放军总医院第一医学中心病理科,北京 100853中国人民解放军总医院第一医学中心病理科,北京 100853中国人民解放军总医院第一医学中心病理科,北京 100853中国人民解放军总医院第一医学中心病理科,北京 100853中国人民解放军总医院第一医学中心病理科,北京 100853

医药卫生

伴淋巴样间质胃癌分子病理错配修复功能缺陷/微卫星高度不稳定EB病毒胃癌

gastric carcinoma with lymphoid stromamolecular pathologydeficient mismatch repair/microsatellite instability-highEpstein-Barr virusgastric carcinoma

《临床与病理杂志》 2026 (8)

1280-1287,8

10.11817/j.issn.2095-6959.2026.260402

评论